Orchid Chemicals and Pharmaceuticals has completed debt recast scheme it initiated in June last year, says report.
Report stated that the process enables the company to pay back dues of Rs2,866 crore to a consortium of lenders.
The proceeds of the sale to Hospira amount to Rs1,134 crore.
No comments:
Post a Comment